A central government panel on vaccine administration for COVID-19 met representatives of leading domestic manufacturers, including Serum Institute of India (SII), Bharat Biotech and Zydus Cadila, on Monday to take inputs about the present stage of various candidate vaccines as well as their expectations from the government. The meeting was mutually beneficial and productive, the health ministry said. “It provided the national expert group with inputs about the present stage of various candidate vaccines being developed by indigenous manufacturers as well as their expectations from the Union government,” the statement said. The meeting was chaired by Niti Aayog member V K Paul and co-chaired by Union Health Secretary Rajesh Bhushan. The panel met separately representatives of the five firms — Serum Institute of India (Pune), Bharat Biotech (Hyderabad), Zydus Cadila (Ahmedabad), Gennova Biopharmaceuticals (Pune) and Biological E (Hyderabad) and discussed the various stages of coronavirus vaccine trials they are at. The panel also asked the drugmakers about their production capacity and whether they need any sort of assistance from the government. This was the second meeting of the committee after August 12.